We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFSW
2801
DELISTED
PFSweb, Inc.
PFSW
$37K ﹤0.01%
8,532
+6,509
+322% +$40.3K
AVNS
2802
DELISTED
Avanos Medical
AVNS
$36K ﹤0.01%
1,201
-1
-0.1% -$29
CQP icon
2803
Cheniere Energy
CQP
$33.3B
$36K ﹤0.01%
756
+71
+10% +$3.63K
CRNC icon
2804
Cerence
CRNC
$391M
$36K ﹤0.01%
1,297
+771
+147% +$19.8K
CTS icon
2805
CTS Corp
CTS
$1.82B
$36K ﹤0.01%
728
+425
+140% +$19K
DCO icon
2806
Ducommun
DCO
$3.04B
$36K ﹤0.01%
655
+353
+117% +$19.2K
ELVN icon
2807
Enliven Therapeutics
ELVN
$4.25B
$36K ﹤0.01%
1,657
+698
+73% +$14.2K
IDV icon
2808
iShares International Select Dividend ETF
IDV
$8.53B
$36K ﹤0.01%
+1,318
New +$37.1K
KFRC icon
2809
Kforce
KFRC
$1.03B
$36K ﹤0.01%
566
+58
+11% +$3.44K
LILAK icon
2810
Liberty Latin America Class C
LILAK
$1.67B
$36K ﹤0.01%
4,803
+537
+13% +$4.28K
LMND icon
2811
Lemonade
LMND
$4.1B
$36K ﹤0.01%
2,523
-2,053
-45% -$31.2K
MODV
2812
DELISTED
ModivCare
MODV
$36K ﹤0.01%
425
+339
+394% +$32.6K
MRUS
2813
DELISTED
Merus
MRUS
$36K ﹤0.01%
1,968
+246
+14% +$4.29K
NNI icon
2814
Nelnet
NNI
$4.52B
$36K ﹤0.01%
393
-731
-65% -$67.7K
PBR.A icon
2815
Petrobras Class A
PBR.A
$104B
$36K ﹤0.01%
3,880
-21,565
-85% -$208K
SMMT icon
2816
Summit Therapeutics
SMMT
$11.2B
$36K ﹤0.01%
20,874
-6,206
-23% -$16.9K
STOK icon
2817
Stoke Therapeutics
STOK
$2.02B
$36K ﹤0.01%
4,293
-30,200
-88% -$272K
TCI icon
2818
Transcontinental Realty Investors
TCI
$318M
$36K ﹤0.01%
834
+525
+170% +$23.4K
TD icon
2819
Toronto Dominion Bank
TD
$204B
$36K ﹤0.01%
600
-11,597
-95% -$749K
TUR icon
2820
iShares MSCI Turkey ETF
TUR
$220M
$36K ﹤0.01%
1,115
-1,340
-55% -$46.1K
ZNTL icon
2821
Zentalis Pharmaceuticals
ZNTL
$297M
$36K ﹤0.01%
2,091
-487
-19% -$9.86K
ASTH icon
2822
Astrana Health
ASTH
$1.78B
$36K ﹤0.01%
1,000
+477
+91% +$16.7K
SQSP
2823
DELISTED
Squarespace, Inc.
SQSP
$36K ﹤0.01%
1,142
-1,118
-49% -$27.6K
MORF
2824
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$36K ﹤0.01%
951
+369
+63% +$13.6K
MDRX
2825
DELISTED
Veradigm Inc. Common Stock
MDRX
$36K ﹤0.01%
2,723
+331
+14% +$5.36K
111 112
113
114 115

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.